| Detected | Trial | Change |
|---|---|---|
| 2026-06-11 | NCT06143046 A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and… |
Trial completed |
| 2026-05-29 | NCT05533697 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade… |
Trial sites expanded: 28 -> 31 locations |
| 2026-05-28 | NCT06880549 A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer… |
Enrollment reduced: 57 -> 42 participants |
| 2026-05-28 | NCT06880549 A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer… |
date change Primary completion moved earlier: 2029-01-10 -> 2027-08-03 |
| 2026-05-28 | NCT06880549 A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer… |
date change Completion moved earlier: 2029-01-10 -> 2027-08-03 |
| 2026-05-19 | NCT05683457 A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-19 | NCT05683457 A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus… |
Enrollment reduced: 224 -> 84 participants |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06585241 | A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing… | SARS-CoV-2 | Recruiting |
| NCT07089706 | A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19… | COVID-19 | Recruiting |
| NCT07266558 | A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50… | SARS-CoV-2 | Active, Not Recruiting |
| Phase 3 | |||
| NCT07496450 | A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults | Influenza | Recruiting |
| NCT06592794 | A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of… | Acute Gastroenteritis | Active, Not Recruiting |
| Phase 2 | |||
| NCT07561294 | A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to… | Lyme Disease | Recruiting |
| NCT05683457 | A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus… | Cytomegalovirus Infection | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT04159103 | Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia | Propionic Acidemia | Recruiting |
| NCT05130437 | A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants… | Propionic Acidemia | Recruiting |
| NCT07116616 | A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma | Relapsed or Refractory Multiple Myeloma | Recruiting |
| NCT05533697 | Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade… | Advanced Solid Tumors | Recruiting |
| NCT05992935 | Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and… | Norovirus Acute Gastroenteritis | Active, Not Recruiting |
| NCT05164094 | A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to… | Epstein-Barr Virus Infection | Active, Not Recruiting |
| Phase 1 | |||
| NCT07478952 | A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18… | Epstein-Barr Virus | Recruiting |
| NCT06655870 | A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously… | Healthy Participants | Active, Not Recruiting |
| NCT03313778 | Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in… | Solid Tumors | Active, Not Recruiting |
| NCT06880549 | A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer… | Advanced Solid Tumors | Active, Not Recruiting |
| Not specified | |||
| NCT05769621 | A Retrospective Study to Characterize Participants With Propionic Acidemia | Propionic Acidemia | Recruiting |
| NCT06333704 | Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT… | SARS-CoV-2 | Active, Not Recruiting |